Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03670225 · ClinicalTrials.gov registry record · NA
Evaluating Clinical Acceptance of a NPWT Wound Care System
A NA study of Diabetic Foot Ulcer and Pressure Ulcer, sponsored by Medela.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03670225: Completed NA study of Diabetic Foot Ulcer and Pressure Ulcer, sponsored by Medela.
NCT03670225 is a NA study of Diabetic Foot Ulcer and Pressure Ulcer that has completed, run by Medela. The registered enrollment target is 10 participants, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03670225, a NA study of Diabetic Foot Ulcer and Pressure Ulcer, has completed, sponsored by Medela.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.
Primary Outcome
Goal of the therapy will be defined by the physician according to initial assessment: * Decrease in wound volume * Decrease in size of the tunneling area * Decrease in size of undermining * Decrease in amount of slough * Increase in granulation tissue * The wound bed is progressing acceptably towards a transition to another treatment modality such as Moist Wound Healing (MWH), surgical closure, or a flap or graft. \*\*Study endpoint will be determined by physician at the time of enrolment, whe
Conditions Studied
Interventions
- DEVICE Invia Motion Endure
Study Locations (1)
Georgia
- Joseph M. Still Research Foundation - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-10-16 |
| Est. Completion | 2020-01-30 |
| Phase | NA |
What the finished NCT03670225 record still lists
NCT03670225 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 255-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which Invia Motion Endure is the first listed.
NCT03670225 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT03670225 about?
NCT03670225 is a clinical study titled "Evaluating Clinical Acceptance of a NPWT Wound Care System". Determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.
What is the current status of trial NCT03670225?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-10-16. Estimated completion is 2020-01-30.
What conditions does trial NCT03670225 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Pressure Ulcer, Pressure Injury.
What interventions are being tested in trial NCT03670225?
The interventions under investigation include: Invia Motion Endure (DEVICE).
Who is sponsoring clinical trial NCT03670225?
This trial is sponsored by Medela, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03670225 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03670225's enrollment target sits among peer trials
10 67th of 67 the lowest of 67 other Diabetic Foot Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI